Search

everythinglearnresearchcommunity

for

Search:↓

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

IL-17-producing γδ T cells help improve bone healing.

Finasteride 2.5 mg/day can effectively treat female hair loss.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

SM04755 may be an effective topical treatment for psoriasis.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Thai rice bran extracts, especially from Tubtim Chumphae rice, can significantly reduce the activity of hair loss genes, with x-tocopherol showing potential as an anti-hair loss product.